147 related articles for article (PubMed ID: 32382359)
21. The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV.
López-Vélez R
Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():143-7. PubMed ID: 14678641
[TBL] [Abstract][Full Text] [Related]
22. The performance of direct agglutination tests (DAT) in the diagnosis of visceral leishmaniasis among Ethiopian patients with HIV co-infection.
Hailu A; Berhe N
Ann Trop Med Parasitol; 2002 Jan; 96(1):25-30. PubMed ID: 11989530
[TBL] [Abstract][Full Text] [Related]
23. Visceral leishmaniasis in Northeast Brazil: What is the impact of HIV on this protozoan infection?
Silva de Lima UR; Vanolli L; Moraes EC; Ithamar JS; Azevedo CMPES
PLoS One; 2019; 14(12):e0225875. PubMed ID: 31805100
[TBL] [Abstract][Full Text] [Related]
24. Does timing of antiretroviral treatment influence treatment outcomes of visceral leishmaniasis in Northwest Ethiopia?
Aderie EM; Diro E; Zachariah R; da Fonseca MS; Abongomera C; Dolamo BL; Ritmeijer K
Trans R Soc Trop Med Hyg; 2017 Mar; 111(3):107-116. PubMed ID: 28633331
[TBL] [Abstract][Full Text] [Related]
25. Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence.
Ritmeijer K; ter Horst R; Chane S; Aderie EM; Piening T; Collin SM; Davidson RN
Clin Infect Dis; 2011 Dec; 53(12):e152-8. PubMed ID: 22016502
[TBL] [Abstract][Full Text] [Related]
26. Exploring prognosis in chronic relapsing visceral leishmaniasis among HIV-infected patients: Circulating Leishmania DNA.
Cota GF; de Sousa MR; de Assis TSM; Pinto BF; Rabello A
Acta Trop; 2017 Aug; 172():186-191. PubMed ID: 28501450
[TBL] [Abstract][Full Text] [Related]
27. Prevalence estimates of human immunodeficiency virus (HIV) infection among visceral leishmaniasis infected people in Northwest Ethiopia: a systematic review and meta-analysis.
Mohebali M; Yimam Y
BMC Infect Dis; 2020 Mar; 20(1):214. PubMed ID: 32164607
[TBL] [Abstract][Full Text] [Related]
28. High levels of anti-Leishmania IgG3 and low CD4
Kuschnir RC; Pereira LS; Dutra MRT; de Paula L; Silva-Freitas ML; Corrêa-Castro G; da Costa Cruz Silva S; Cota G; Santos-Oliveira JR; Da-Cruz AM
BMC Infect Dis; 2021 Apr; 21(1):369. PubMed ID: 33874901
[TBL] [Abstract][Full Text] [Related]
29. Case Report: Atypical Presentation of Visceral Leishmaniasis: Two Cases from Northwest Ethiopia.
Mohammed R; Fikre H; Mekonnen T; Abebe B; Yeshanew A; Diro E; van Griensven J
Am J Trop Med Hyg; 2021 Apr; 104(6):2082-2084. PubMed ID: 33844644
[TBL] [Abstract][Full Text] [Related]
30. Development and comparative evaluation of two antigen detection tests for Visceral Leishmaniasis.
Vallur AC; Tutterrow YL; Mohamath R; Pattabhi S; Hailu A; Abdoun AO; Ahmed AE; Mukhtar M; Salam MA; Almeida ML; Almeida RP; Mondal D; Albertini A; Ghalib H; Duthie MS; Reed SG
BMC Infect Dis; 2015 Sep; 15():384. PubMed ID: 26395447
[TBL] [Abstract][Full Text] [Related]
31. New world Leishmania spp. infection in people living with HIV: Concerns about relapses and secondary prophylaxis.
Araújo CF; Oliveira IBN; Silva MVT; Pereira LIA; Pinto SA; Silveira MB; Dorta ML; Fonseca SG; Gomes RS; Ribeiro-Dias F
Acta Trop; 2021 Dec; 224():106146. PubMed ID: 34562423
[TBL] [Abstract][Full Text] [Related]
32. Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia.
Diro E; Edwards T; Ritmeijer K; Fikre H; Abongomera C; Kibret A; Bardonneau C; Soipei P; Mutinda B; Omollo R; van Griensven J; Zijlstra EE; Wasunna M; Alves F; Alvar J; Hailu A; Alexander N; Blesson S
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007132. PubMed ID: 30789910
[TBL] [Abstract][Full Text] [Related]
33. Role of asymptomatic and symptomatic humans as reservoirs of visceral leishmaniasis in a Mediterranean context.
Molina R; Jiménez M; García-Martínez J; San Martín JV; Carrillo E; Sánchez C; Moreno J; Alves F; Alvar J
PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008253. PubMed ID: 32324738
[TBL] [Abstract][Full Text] [Related]
34. [The clinical and evolutional characteristics of visceral leishmaniasis in patients with HIV infection].
Delgado Fernández M; García Ordoñez MA; Martos Pérez F; Reguera Iglesias JM; Jiménez Oñate F; Colmenero Castillo JD
An Med Interna; 1997 Oct; 14(10):506-10. PubMed ID: 9424140
[TBL] [Abstract][Full Text] [Related]
35. Epidemiological profile of patients co-infected with visceral leishmaniasis and HIV/AIDS in Northeast, Brazil.
Viana GMC; Silva MACND; Garcia JVS; Guimarães HD; Arcos GF; Santos AVA; Paixão PVD; Nascimento MDDSB; Galvão CS
Rev Soc Bras Med Trop; 2017; 50(5):613-620. PubMed ID: 29160507
[TBL] [Abstract][Full Text] [Related]
36. High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia.
Diro E; Lynen L; Mohammed R; Boelaert M; Hailu A; van Griensven J
PLoS Negl Trop Dis; 2014 May; 8(5):e2875. PubMed ID: 24854196
[TBL] [Abstract][Full Text] [Related]
37. Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients.
Adriaensen W; Abdellati S; van Henten S; Gedamu Y; Diro E; Vogt F; Mengesha B; Adem E; Kestens L; van Griensven J
Front Cell Infect Microbiol; 2018; 8():428. PubMed ID: 30619775
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism in the HASPB repeat region of East African Leishmania donovani strains.
Zackay A; Nasereddin A; Takele Y; Tadesse D; Hailu W; Hurissa Z; Yifru S; Weldegebreal T; Diro E; Kassahun A; Hailu A; Jaffe CL
PLoS Negl Trop Dis; 2013; 7(1):e2031. PubMed ID: 23358849
[TBL] [Abstract][Full Text] [Related]
39. Analysis of genetic polymorphisms and tropism in East African Leishmania donovani by Amplified Fragment Length Polymorphism and kDNA minicircle sequencing.
Jaber HT; Hailu A; Pratlong F; Lami P; Bastien P; Jaffe CL
Infect Genet Evol; 2018 Nov; 65():80-90. PubMed ID: 30016714
[TBL] [Abstract][Full Text] [Related]
40. High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran.
Rezaei Z; Sarkari B; Dehghani M; Layegh Gigloo A; Afrashteh M
Parasitol Res; 2018 Aug; 117(8):2591-2595. PubMed ID: 29860572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
